Search the GHTC website

Latest news

Check out the latest news and announcements from GHTC.

May 13, 2022

GHTC delivers statement on global TB research and innovation strategy at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session calling for the US government to support increased investments in tuberculosis (TB) R&D, improved coordination through global platforms, and streamlined processes for adding new tools to essential product lists and releasing treatment guidelines.

Recent news

  • Sort order:
May 13, 2022

GHTC delivers statement on global TB research and innovation strategy at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session calling for the US government to support increased investments in tuberculosis (TB) R&D, improved coordination through global platforms, and streamlined processes for adding new tools to essential product lists and releasing treatment guidelines.

May 13, 2022

GHTC delivers statement on Immunization Agenda 2030 at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session calling on the US government to help strengthen implementation of recommendations from the World Health Organization’s expert body on immunization, accelerate the R&D agenda to advance next-generation COVID-19 vaccines, and support research on the full spectrum of needed immunization innovations, including vaccine administration tools and storage and delivery innovations.

May 13, 2022

GHTC delivers statement on NTDs roadmap at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session urging to US government to invest in R&D for new treatment and prevention tools for neglected tropical diseases (NTDs) and work with the World Health Organization to address the current diagnostic gap for NTDs and advance regulatory pathways for diagnostic products.

May 13, 2022

GHTC submits statement on clinical trial strengthening resolution via HHS WHA listening session

GHTC submitted a statement to the US Department of Health and Human Services (HHS) as part of the World Health Assembly (WHA) Stakeholder Listening Session urging the US government to support a draft WHA resolution from the United Kingdom that proposes actions to strengthen clinical trial protocols, coordination, and data sharing and bolster clinical trial capacity in low- and middle-income countries.

May 11, 2022

GHTC pledges commitments for 2nd Global COVID-19 Summit

Ahead of the 2nd Global COVID-19 Summit tomorrow, GHTC Executive Director Jamie Bay Nishi shared the coalition’s commitments to advancing COVID-19 technologies for low-resource settings and strengthening regionally distributed R&D capacity.